Find clinical trials for Triple Negative Breast Cancer in Columbus, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Columbus, OH, USA:
This study will look to establish the recommended biologic dose of AE37 in combination with pembrolizumab that will enhance the tumor-specif-...
Phase 2
Columbus, Ohio, United States and 5 other locations
pelareorep and to see how well they work in treating patients with triple negative breast cancer that has spread ...
Phase 2
Columbus, Ohio, United States and 1 other location
This research study is studying a drug called Carboplatin with or without another study drug, Nivolumab as a possible treatment for triple-n ...
Phase 2
Columbus, Ohio, United States and 9 other locations
doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...
Phase 3
Columbus, Ohio, United States and 216 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Columbus, Ohio, United States and 166 other locations
to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patients with select advanced solid tumors...
Phase 1
Hillard, Ohio, United States and 20 other locations
Event Free Survival (EFS), in women with residual hormone receptor negative, HER2-negative ("triple negative") re ...
Phase 2
Columbus, Ohio, United States and 3 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...
Phase 3
Columbus, Ohio, United States of America and 516 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...
Phase 3
Columbus, Ohio, United States and 505 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Columbus, Ohio, United States and 360 other locations
Clinical trials
Research sites
Resources
Legal